Wyeth Honored by Cambridge Chamber of Commerce

CAMBRIDGE, Mass., May 25 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, the pharmaceutical division of Wyeth , announced today that its Cambridge Research Campus received the Leading Edge Award at the Cambridge Chamber of Commerce annual gala. The Leading Edge Award is given annually to a Cambridge-based company or institution for demonstrating outstanding leadership and innovation in the life sciences industry. Lee F. Allen, M.D., Ph.D., Vice President, Oncology Clinical Research & Development and Cambridge Site Head, accepted the award on behalf of the Company at the Chamber's Annual Excellence in Business Awards gala event last night in Cambridge, Mass.

"Wyeth is honored to be recognized by the Chamber as a leader that has made significant contributions to the life sciences industry," says Dr. Allen, Vice President of Clinical Research and Development of Wyeth Research in Cambridge, Mass. "The Leading Edge Award acknowledges the tremendous pioneering effort of Wyeth's more than 900 employees in Cambridge striving to discover and develop therapies that will address significant medical needs."

Wyeth's Cambridge research campus is home to the company's Oncology Center of Excellence, where clinicians are designing innovative clinical development programs for its cutting-edge portfolio of anti-cancer agents, targeting the treatment of renal cell carcinoma, metastatic breast cancer, mantle cell lymphoma, non-small cell lung cancer and several other tumors. Clinical development programs in the areas of hemophilia and bone and tissue repair are also led from the Cambridge site.

The Cambridge campus is Wyeth's largest discovery research site where preclinical research is underway for new therapies for hemophilia, inflammation, metabolic diseases, cardiovascular diseases, as well as bone and tissue repair. The Cambridge site has conducted groundbreaking research resulting in recombinant treatments for hemophilia A and B and a bone morphogenic protein that induces bone growth to repair bone fractures.

About the Cambridge Chamber of Commerce

The Cambridge Chamber of Commerce is a 1,400-member, not-for-profit organization (http://www.cambridgechamber.org/) representing all sectors of the Cambridge economy. Its diverse membership and deep expertise in government affairs, business development, professional development and business philanthropy attract employers of all sizes. Since its inception, the Chamber has actively engaged local business leaders in governmental and philanthropic activities, connecting and educating its members, and providing a forum for addressing the needs of the Cambridge business community.

About Wyeth Research & Development in Cambridge, Massachusetts

Wyeth Pharmaceuticals, a division of Wyeth [NYSE: WYE], has a long history of pioneering developments in the areas of women's health care, cardiovascular and metabolic diseases, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide.

Media Contact: Investor Contact: Gerald Burr Justin Victoria Wyeth Pharmaceuticals Wyeth (484) 865-5138 (973) 660-5340